The long term goal of this proposal by the Ontario Family Registry (OFR) is to participate as part of the CFRBCS to complete the establishment of a hypothesis-driven interdisciplinary research platform to support, expedite and implement research in genetic epidemiology of breast cancer. The OFR contains a population-based cohort of breast cancer cases, identified as incident cases from the Ontario Cancer Registry from 1996 to 1998, and their families. In addition, the OFR contains prevalent AJ cases and their families recruited at familial cancer clinics. We have developed an extensive system for the identification of population-based incident breast cancer cases and the collection of family history, epidemiologic information, blood, and tissue specimens.
The specific aims of the renewal of the ORF are: 1) To enhance the value of the OFR by completing the collection of data and biospecimens from probands, extending the collection of data and biospecimens from relatives and recruiting additional subjects (minorities and Ashkenazim Jewish) into the OFR 2) To maintain a functioning OFR database and biospecimen repository 3) To participate in a broad spectrum of scientific studies, including clinical, pathological, gene discovery, gene-environment, genetic modifiers, and psycho-social. 4) To provide a resource for collaborative studies involving the CFRBCS sites and external collaborators This information will lead to an improved understanding of the contributions made to the etiology of breast cancer by genetic and environmental factors, to identify the factors, responsible, and to gain an understanding of how they act, both separately and together, to influence breast cancer risk.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA069467-10
Application #
6791173
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O2))
Program Officer
Seminara, Daniela
Project Start
1995-09-30
Project End
2005-11-30
Budget Start
2004-07-09
Budget End
2004-11-30
Support Year
10
Fiscal Year
2004
Total Cost
$1,137,619
Indirect Cost
Name
Cancer Care Ontario
Department
Type
DUNS #
243657665
City
Toronto
State
ON
Country
Canada
Zip Code
M5 2-L7
Dite, Gillian S; MacInnis, Robert J; Bickerstaffe, Adrian et al. (2017) Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer. Am J Epidemiol 185:487-500
Barrdahl, Myrto; Rudolph, Anja; Hopper, John L et al. (2017) Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. Int J Cancer 141:1830-1840
Dite, Gillian S; MacInnis, Robert J; Bickerstaffe, Adrian et al. (2016) Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 25:359-65
Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2 (see original citation for additional authors) (2016) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol 141:386-401
Southey, Melissa C (see original citation for additional authors) (2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53:800-811
Lin, Wei-Yu (see original citation for additional authors) (2015) Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Hum Mol Genet 24:285-98
Rudolph, Anja; Milne, Roger L; Truong, Thérèse et al. (2015) Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. Int J Cancer 136:E685-96
Antoniou, Antonis C; Casadei, Silvia; Heikkinen, Tuomas et al. (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497-506
Johnson, Nichola; Dudbridge, Frank; Orr, Nick et al. (2014) Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Res 16:R51
Ahsan, Habibul; Halpern, Jerry; Kibriya, Muhammad G et al. (2014) A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev 23:658-69

Showing the most recent 10 out of 104 publications